These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

252 related articles for article (PubMed ID: 8569021)

  • 21. The new antibiotics.
    Breithaupt H
    Nat Biotechnol; 1999 Dec; 17(12):1165-9. PubMed ID: 10585711
    [No Abstract]   [Full Text] [Related]  

  • 22. Resilient bacteria making our antibiotics ineffective.
    Can Oper Room Nurs J; 1987 Feb; 5(1):6-9. PubMed ID: 3644692
    [No Abstract]   [Full Text] [Related]  

  • 23. Statewide surveillance for antibiotic-resistant bacteria--New Jersey, 1992-1994.
    Centers for Disease Control and Prevention (CDC)
    MMWR Morb Mortal Wkly Rep; 1995 Jul; 44(27):504-6. PubMed ID: 7596335
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Mechanisms of bacterial resistance to antimicrobial agents.
    Stratton CW
    J Med Liban; 2000; 48(4):186-98. PubMed ID: 11214188
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Molecular epidemiologic analysis of antibiotic resistant microorganisms.
    John JF
    Adv Exp Med Biol; 1995; 390():155-68. PubMed ID: 8718610
    [No Abstract]   [Full Text] [Related]  

  • 26. [The problem and current situation of drug-resistant bacteria in medical settings].
    Matsumoto T
    Rinsho Byori; 2012 Oct; 60(10):955-8. PubMed ID: 23323459
    [No Abstract]   [Full Text] [Related]  

  • 27. The origins and molecular basis of antibiotic resistance.
    Hawkey PM
    BMJ; 1998 Sep; 317(7159):657-60. PubMed ID: 9727999
    [No Abstract]   [Full Text] [Related]  

  • 28. Therapeutic challenges posed by bacterial bioterrorism threats.
    Gilligan PH
    Curr Opin Microbiol; 2002 Oct; 5(5):489-95. PubMed ID: 12354556
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Status of antibiotic use in India.
    Parikh F
    J Assoc Physicians India; 2010 Dec; 58 Suppl():7. PubMed ID: 21568006
    [No Abstract]   [Full Text] [Related]  

  • 30. Vaccines and antibiotic resistance.
    Mishra RP; Oviedo-Orta E; Prachi P; Rappuoli R; Bagnoli F
    Curr Opin Microbiol; 2012 Oct; 15(5):596-602. PubMed ID: 22981392
    [TBL] [Abstract][Full Text] [Related]  

  • 31. The 1997 Garrod Lecture. The subtleties of antibiotic resistance.
    Phillips I
    J Antimicrob Chemother; 1998 Jul; 42(1):5-12. PubMed ID: 9700524
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Prospects for new antibiotics: a molecule-centered perspective.
    Walsh CT; Wencewicz TA
    J Antibiot (Tokyo); 2014 Jan; 67(1):7-22. PubMed ID: 23756684
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Nature's clarion call of antibacterial resistance: are we listening?
    Theuretzbacher U; Toney JH
    Curr Opin Investig Drugs; 2006 Feb; 7(2):158-66. PubMed ID: 16499286
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Methodology of prevention of antibiotic resistance.
    Shetty A
    J Assoc Physicians India; 2010 Dec; 58 Suppl():47-8. PubMed ID: 21568010
    [No Abstract]   [Full Text] [Related]  

  • 35. Alteration of the body flora by antibiotics--can it be avoided?
    Geddes AM
    Scand J Infect Dis Suppl; 1986; 49():131-4. PubMed ID: 3469747
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Antibiotic resistance in bacteria.
    Amyes SG; Gemmell CG
    J Med Microbiol; 1992 Jan; 36(1):4-29. PubMed ID: 1731057
    [No Abstract]   [Full Text] [Related]  

  • 37. New approaches to developing antimicrobials for resistant bacteria.
    Moellering RC
    J Infect Chemother; 2003 Mar; 9(1):8-11. PubMed ID: 12673399
    [No Abstract]   [Full Text] [Related]  

  • 38. Anti-virulence strategies to combat bacteria-mediated disease.
    Rasko DA; Sperandio V
    Nat Rev Drug Discov; 2010 Feb; 9(2):117-28. PubMed ID: 20081869
    [TBL] [Abstract][Full Text] [Related]  

  • 39. [Fighting antibiotic resistance].
    Harthug S; Akselsen PE
    Tidsskr Nor Laegeforen; 2008 Oct; 128(20):2343-6. PubMed ID: 19096492
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Lack of development of new antimicrobial drugs: a potential serious threat to public health.
    Norrby SR; Nord CE; Finch R;
    Lancet Infect Dis; 2005 Feb; 5(2):115-9. PubMed ID: 15680781
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 13.